Molecular Characterization of Carbapenem-Resistant Serratia marcescens Clinical Isolates in a Tertiary Hospital in Hangzhou, China

References

• Guh AY, Bulens SN, Mu Y, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012–2013. JAMA. 2015;314(14):1479–1487. doi:10.1001/jama.2015.1248026436831
   PubMed Web of Science ®Google Scholar
• Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301. doi:10.1017/ice.2016.17427573805
   PubMed Web of Science ®Google Scholar
• Walters MS, Witwer M, Lee Y-K, et al. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae from less common Enterobacteriaceae Genera — United States, 2014–2017. MMWR Morb Mortal Wkly Rep. 2018;67(23):668–669. doi:10.15585/mmwr.mm6723a429902165
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 29th CLSI supplement M100 Wayne, PA: CLSI; 2019
   Google Scholar
• Zhang R, Zhou HW, Cai JC, et al. Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother. 2007;59(3):574–576. doi:10.1093/jac/dkl54117251347
   PubMed Web of Science ®Google Scholar
• Cai JC, Zhou HW, Zhang R, et al. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother. 2008;52(6):2014–2018. doi:10.1128/AAC.01539-0718332176
   PubMed Web of Science ®Google Scholar
• Hejazi A, Falkiner FR. Serratia marcescens. J Med Microbiol. 1997;46(11):903–912. doi:10.1099/00222615-46-11-9039368530
   PubMed Web of Science ®Google Scholar
• Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev. 2011;24(4):755-+. doi:10.1128/cmr.00017-11
   Web of Science ®Google Scholar
• Yokota M, Okazawa A, Tanaka T. Serratia marcescens as an opportunistic human pathogen. Nihon saikingaku zasshi. Jpn J Bacteriol. 2001;56(3):527–535. doi:10.3412/jsb.56.527
   Google Scholar
• Sakai S, Nishio A, Kumamoto Y. [Clinical studies on urinary tract infections caused by Serratia marcescens. II. Epidemiological studies on onset of Serratia marcescens urinary tract infections in the urological ward]. Jpn j Urol. 1983;74(4):485–502. doi:10.5980/jpnjurol1928.74.4_485. Japanese.
   Google Scholar
• Theccanat G, Hirschfield L, Isenberg H. SERRATIA-MARCESCENS MENINGITIS. J Clin Microbiol. 1991;29(4):822–823. doi:10.1128/JCM.29.4.822-823.19911890185
   PubMed Web of Science ®Google Scholar
• Hogman CF, Fritz H, Sandberg L. Posttransfusion Serratia-Marcescens Septicemia. Transfusion. 1993;33(3):189–191. doi:10.1046/j.1537-2995.1993.33393174441.x8438217
   PubMed Web of Science ®Google Scholar
• Byrne AH, Boyle B, Herra CM, et al. Serratia marcescens causing hospital-acquired lower respiratory tract infection. J Hosp Infect. 2000;45(3):242–244. doi:10.1053/jhin.2000.076110896806
   PubMed Web of Science ®Google Scholar
• Pak KY, Kim SI, Lee JS. Neonatal bacterial conjunctivitis in Korea in the 21st century. Cornea. 2017;36(4):415–418. doi:10.1097/ICO.000000000000112228002109
   PubMed Web of Science ®Google Scholar
• Us E, Kutlu HH, Tekeli A, et al. Wound and soft tissue infections of Serratia marcescens in patients receiving wound care: a health care-associated outbreak. Am J Infect Control. 2017;45(4):443–447. doi:10.1016/j.ajic.2016.11.01528063729
   PubMed Web of Science ®Google Scholar
• Schechter MC, Spicer JO, Del Mar Aldrete S, et al. Serratia marcescens infectious endocarditis: injection drug use, left-sided heart disease, and poor outcomes. Infect Dis Clin Pract. 2018;26(4):216–219. doi:10.1097/IPC.0000000000000614
   Web of Science ®Google Scholar
• Dessi A, Puddu M, Testa M, et al. Serratia marcescens infections and outbreaks in neonatal intensive care units. J Chemother. 2009;21(5):493–499. doi:10.1179/joc.2009.21.5.49319933039
   PubMed Web of Science ®Google Scholar
• Ruiz-Sada P, Escalante M, Lizarralde E. Severe acute infection due to Serratia marcescens causing respiratory distress in an immunocompetent adult. Rom J Intern Med. 2016;54(2):134–136. doi:10.1515/rjim-2016-001327352443
   PubMedGoogle Scholar
• Bryant KA, Van Schooneveld TC, Thapa I, et al. KPC-4 is encoded within a truncated Tn4401 in an IncL/M plasmid, pNE1280, isolated from Enterobacter cloacae and Serratia marcescens. Antimicrob Agents Chemother. 2013;57(1):37–41. doi:10.1128/AAC.01062-1223070154
   PubMed Web of Science ®Google Scholar
• Gona F, Caio C, Iannolo G, et al. Detection of the IncX3 plasmid carrying bla(KPC-3) in a Serratia marcescens strain isolated from a kidney–liver transplanted patient. J Med Microbiol. 2017;66(10):1454–1456. doi:10.1099/jmm.0.00059228920846
   PubMed Web of Science ®Google Scholar
• Kern WV, Steinke P, Schumacher A, et al. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother. 2006;57(2):339–343. doi:10.1093/jac/dki44516354747
   PubMed Web of Science ®Google Scholar
• Ligozzi M, Fontana R, Aldegheri M, et al. Comparative evaluation of an automated repetitive-sequence-based PCR instrument versus pulsed-field gel electrophoresis in the setting of a Serratia marcescens nosocomial infection outbreak. J Clin Microbiol. 2010;48(5):1690–1695. doi:10.1128/JCM.01528-0920237095
   PubMed Web of Science ®Google Scholar
• Miao M, Wen H, Xu P, et al. Genetic diversity of carbapenem-resistant Enterobacteriaceae (CRE) clinical isolates from a tertiary hospital in Eastern China. Front Microbiol. 2019;9. doi:10.3389/fmicb.2018.03341
   Web of Science ®Google Scholar
• Wang L, Fang H, Feng J, et al. Complete sequences of KPC-2-encoding plasmid p628-KPC and CTX-M-55-encoding p628-CTXM coexisted in Klebsiella pneumoniae. Front Microbiol. 2015;6. doi:10.3389/fmicb.2015.00838
   Web of Science ®Google Scholar
• Tang Y, Shen P, Liang W, et al. A putative multi-replicon plasmid co-harboring beta-lactamase genes bla(KPC-2), bla(CTX-M-14) and bla(TEM-1) and trimethoprim resistance gene dfrA25 from a Klebsiella pneumoniae sequence type (ST) 11 strain in China. PLoS One. 2017;12(2). doi:10.1371/journal.pone.0186097.
   Web of Science ®Google Scholar
• Chen L, Mathema B, Chavda KD, et al. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 2014;22(12):686–696. doi:10.1016/j.tim.2014.09.00325304194
   PubMed Web of Science ®Google Scholar
• Liu P, Li P, Jiang X, et al. Complete genome sequence of Klebsiella pneumoniae subsp pneumoniae HS11286, a multidrug-resistant strain isolated from human sputum. J Bacteriol. 2012;194(7):1841–1842. doi:10.1128/JB.00043-1222408243
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yu D, Wei Z, et al. Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying bla(KPC-2), bla(DHA-1), qnrB4, and armA. Antimicrob Agents Chemother. 2010;54(9):3967–3969. doi:10.1128/AAC.00137-1020547789
   PubMed Web of Science ®Google Scholar
• da Costa Guimaraes AC, Almeida ACS, Nicoletti AG, et al. Clonal spread of carbapenem-resistant Serratia marcescens isolates sharing an IncK plasmid containing bla(KPC-2). Int J Antimicrob Agents. 2013;42(4):369–370. doi:10.1016/j.ijantimicag.2013.05.01723891433
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Brengi S, Cáceres MA, et al. Polyclonal dissemination of KPC-2 in Serratia marcescens, including a clone with epidemic behaviour in the nosocomial niche. Int J Antimicrob Agents. 2017;49(5):657–658. doi:10.1016/j.ijantimicag.2017.03.00328336311
   PubMed Web of Science ®Google Scholar
• Kluytmans-van den Bergh MFQ, Rossen JWA, Bruijning-Verhagen PCJ, et al. Whole-genome multilocus sequence typing of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2016;54(12):2919–2927. doi:10.1128/JCM.01648-1627629900
   PubMed Web of Science ®Google Scholar
• Liu -Y-Y, Chen -C-C, Chiou C-S. Construction of a pan-genome allele database of Salmonella enterica serovar enteritidis for molecular subtyping and disease cluster identification. Front Microbiol. 2016;7. doi:10.3389/fmicb.2016.02010
   Web of Science ®Google Scholar
• Yang H, Cheng J, Hu L, et al. Mechanisms of antimicrobial resistance in Serratia marcescens. Afr J Microbiol Res. 2012;6(21):4427–4437. doi:10.5897/AJMR11.1545
   Google Scholar
• Sun Y, Zhang H, Liu J, et al. The mechanism of carbapenems resistance in Serratia marcescens strains. Chin J Microbiol Immunol. 2014;34(10):774–779.
   Google Scholar
• Guo P, Qiao Y, Zhang H, et al. Profile and mechanism of imipenem resistance in clinical isolates of Serratia marcescens. Chin J Infect Chemother. 2017;17(2):187–191.
   Google Scholar
• Suh B, Bae IK, Kim J, et al. Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-Lactamase overproduction and outer membrane protein loss. Antimicrob Agents Chemother. 2010;54(12):5057–5061. doi:10.1128/AAC.00768-1020876374
   PubMed Web of Science ®Google Scholar
• Liu X-Q, Wang J, Li W, et al. Distribution of cfr in Staphylococcus spp. and Escherichia coli strains from pig farms in China and Characterization of a Novel cfr-Carrying F43: A-:B-Plasmid. Front Microbiol. 2017;8:329. doi:10.3389/fmicb.2017.0032928293235
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Brengi S, Cáceres MA, et al. Successful management with fosfomycin + ceftazidime of an infection caused by multiple highly-related subtypes of multidrug-resistant and extensively drug-resistant KPC-producing Serratia marcescens. Int J Antimicrob Agents. 2018;52(5):737–739. doi:10.1016/j.ijantimicag.2018.07.02030092272
   PubMed Web of Science ®Google Scholar
• Gaudereto JJ, Perdigão Neto LV, Leite GC, et al. Synergistic effect of ceftazidime-avibactam with meropenem against panresistant, carbapenemase-harboring acinetobacter baumannii and Serratia marcescens investigated using time-kill and disk approximation assays. Antimicrob Agents Chemother. 2019;63(5). doi:10.1128/AAC.02367-18.
   Web of Science ®Google Scholar